Neurodevelopmental Outcomes in ZIKV-Exposed Children

Enrolling by invitationOBSERVATIONAL
Enrollment

204

Participants

Timeline

Start Date

November 23, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Zika VirusCongenital Zika SyndromeCongenital InfectionChild Development
Interventions
OTHER

Neurodevelopmental assessments

The investigators will evaluate multiple domains of neurodevelopment at age 3, 4, 5 and 7 years using parental questionnaires and child exams. At age 7 years, the children will have a non-sedated quantitative brain MRI.

Trial Locations (2)

20010

Children's National Hospital, Washington D.C.

Unknown

Biomelab, Barranquilla

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Children's National Research Institute

OTHER